Select a section from the left sidebar
Cocciferin T1
- Family: Plantae - Fagaceae
- Kingdom: Plantae
- Class: Tannin
Canonical Smiles | OC1OC2COC(=O)c3cc(Oc4c(cc(c(c4O)O)O)C(=O)OC4OC5COC(=O)c6cc(Oc7c(cc(c(c7O)O)O)C(=O)O[C@@H]7C(COC(=O)c8cc(O)c(c(c8)O)O)OC([C@H](C7OC(=O)c7cc(O)c(c(c7)O)O)OC(=O)c7cc(O)c(c(c7)O)O)OC(=O)c7cc(O)c(c(c7)O)O)c(c(c6c6c(C(=O)O[C@H]5[C@@H]([C@@H]4OC(=O)c4cc(O)c(c(c4)O)O)Oc4cc(O)c(c(c4)O)O)cc(O)c(c6O)O)O)O)c(c(c3c3c(C(=O)OC2[C@H]2[C@@H]1OC(=O)c1cc(O)c(c(c1c1c(C(=O)O2)cc(c(c1O)O)O)O)O)cc(O)c(c3O)O)O)O |
---|---|
InChI | InChI=1S/C115H82O73/c116-38-1-24(2-39(117)67(38)134)100(156)170-22-59-93(96(182-101(157)25-3-40(118)68(135)41(119)4-25)99(186-103(159)27-7-44(122)70(137)45(123)8-27)114(177-59)187-104(160)28-9-46(124)71(138)47(125)10-28)181-111(167)36-17-54(132)77(144)87(154)89(36)174-56-20-35-66(86(153)79(56)146)64-31(14-51(129)76(143)84(64)151)108(164)180-92-60(23-172-106(35)162)178-115(98(95(92)173-29-11-48(126)72(139)49(127)12-29)185-102(158)26-5-42(120)69(136)43(121)6-26)188-112(168)37-18-55(133)78(145)88(155)90(37)175-57-19-34-65(85(152)80(57)147)63-30(13-50(128)75(142)83(63)150)107(163)179-91-58(21-171-105(34)161)176-113(169)97-94(91)183-109(165)32-15-52(130)73(140)81(148)61(32)62-33(110(166)184-97)16-53(131)74(141)82(62)149/h1-20,58-60,91-99,113-155,169H,21-23H2/t58?,59?,60?,91?,92-,93-,94+,95+,96?,97+,98+,99+,113?,114?,115?/m1/s1 |
InChIKey | AJHDKYFWRKDQKY-VQPVHUJQSA-N |
Formula | C115H82O73 |
HBA | 73 |
HBD | 41 |
MW | 2631.85 |
Rotatable Bonds | 21 |
TPSA | 1226.71 |
LogP | 5.04 |
Number Rings | 20 |
Number Aromatic Rings | 14 |
Heavy Atom Count | 188 |
Formal Charge | 0 |
Fraction CSP3 | 0.16 |
Exact Mass | 2630.27 |
Number of Lipinski Rule Violations | 4 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Quercus coccifera | Fagaceae | Plantae | 58335 |
Showing of synonyms
Cocciferin T1
No compound-protein relationship available.
No scaffolds available.
Antimicrobial
Absorption
- Caco-2 (logPapp)
- -
- Human Oral Bioavailability 20%
- -
- Human Intestinal Absorption
- -
- Madin-Darby Canine Kidney
- -
- Human Oral Bioavailability 50%
- -
- P-Glycoprotein Inhibitor
- -
- P-Glycoprotein Substrate
- -
- Skin Permeability
- -
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- -
- Fraction Unbound (Human)
- -
- Plasma Protein Binding
- -
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- -
- CYP 1A2 Inhibitor
- -
- CYP 1A2 Substrate
- -
- CYP 2C19 Inhibitor
- -
- CYP 2C19 Substrate
- -
- CYP 2C9 Inhibitor
- -
- CYP 2C9 Substrate
- -
- CYP 2D6 Inhibitor
- -
- CYP 2D6 Substrate
- -
- CYP 3A4 Inhibitor
- -
- CYP 3A4 Substrate
- -
- OATP1B1
- -
- OATP1B3
- -
Excretion
- Clearance
- -
- Organic Cation Transporter 2
- -
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- -
- Avian
- -
- Bee
- -
- Bioconcentration Factor
- -
- Biodegradation
- -
- Carcinogenesis
- -
- Crustacean
- -
- Liver Injury I (DILI)
- -
- Eye Corrosion
- -
- Eye Irritation
- -
- Maximum Tolerated Dose
- -
- Liver Injury II
- -
- hERG Blockers
- -
- Daphnia Maga
- -
- Micronucleos
- -
- NR-AhR
- -
- NR-AR
- -
- NR-AR-LBD
- -
- NR-Aromatase
- -
- NR-ER
- -
- NR-ER-LBD
- -
- NR-GR
- -
- NR-PPAR-gamma
- -
- NR-TR
- -
- T. Pyriformis
- -
- Rat (Acute)
- -
- Rat (Chronic Oral)
- -
- Fathead Minnow
- -
- Respiratory Disease
- -
- Skin Sensitisation
- -
- SR-ARE
- -
- SR-ATAD5
- -
- SR-HSE
- -
- SR-MMP
- -
- SR-p53
- -
General Properties
- Boiling Point
- -
- Hydration Free Energy
- -
- Log(D) at pH=7.4
- -
- Log(P)
- -
- Log S
- -
- Log(Vapor Pressure)
- -
- Melting Point
- -
- pKa Acid
- -
- pKa Basic
- -
No predicted protein targets found for this compound.